I'm long GILD, but the fact is that the firm is not trying to make money off of Remdesivir at this point.
PFE's charts are constructive and traders could go long at current levels.
Money movers are not buying protection for individual names, but they are starting to bet against the market en masse, while the Russell 2000 ran up 4% on Monday.
India's drugmakers aim to manufacture generic versions of any coronavirus 'cure', even before the full findings as to how effective they are.
More government funding is approved to fight Covid-19 layoffs, Gilead sells off on early reports around China trials and Intel announces earnings.
Let's take a look at the charts and indicators.
Let's review the charts and indicators.
Trading action has been jumpy, so where's the trend?
You can't rush drugs to market and you can't rush a market bottom.
With a $1 trillion bond, we could be sure that we have national testing and everyone has to be tested, we could actually build the PPE factories and put people to work.